Ernexa Therapeutics (ERNAW) Cash from Operations (2010 - 2026)
Ernexa Therapeutics (ERNAW) reported Cash from Operations of 2300000.0 for Q1 2026, down 11.38% on a YoY basis from 2595355.19 in Q1 2025, and down 100.35% quarter-over-quarter from 1148000.0 in Q4 2025.
Ernexa Therapeutics (ERNAW) Cash from Operations (2010 - 2026) Analysis & Trends
Ernexa Therapeutics has reported Cash from Operations for 17 years, with the latest figure at 2300000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 11.38% year-over-year to 2300000.0; the trailing twelve-month figure through Mar 2026 stood at 7252000.0 (up 48.76% YoY), and the FY2025 full-year result was 7017000.0, up 55.69% from the prior year.
- Cash from Operations for Q1 2026 stood at 2300000.0, down from 1148000.0 in the prior quarter.
- The five-year high for Cash from Operations was 1148000.0 in Q4 2025, with the low at 6285000.0 in Q3 2024.
- Historically, Cash from Operations has averaged 3913941.18 across 5 years, with a median of 3872000.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 58.37% — and 2025, when it jumped 79.81%.
- Ernexa Therapeutics' Cash from Operations stood at 5435000.0 in 2022, then grew by 14.24% to 4661000.0 in 2023, then climbed by 23.94% to 3545000.0 in 2024, then jumped by 67.62% to 1148000.0 in 2025, then sank by 100.35% to 2300000.0 in 2026.
- The last three Cash from Operations figures came in at 2300000.0 (Q1 2026), 1148000.0 (Q4 2025), and 1269000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | -2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.30 Mn |
| Mar 31, 2026 | -2.30 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -2.54 Mn |
| Jun 30, 2025 | -2.54 Mn |
| Mar 31, 2025 | -2.07 Mn |
| Mar 31, 2025 | -2.07 Mn |
| Dec 31, 2024 | -3.55 Mn |
| Dec 31, 2024 | -3.55 Mn |
| Sep 30, 2024 | -6.29 Mn |
| Sep 30, 2024 | -6.29 Mn |
| Jun 30, 2024 | -2.26 Mn |
| Jun 30, 2024 | -2.26 Mn |
| Mar 31, 2024 | -3.75 Mn |
| Mar 31, 2024 | -3.75 Mn |
| Dec 31, 2023 | -4.66 Mn |
| Dec 31, 2023 | -4.66 Mn |